Methotrexate and 5-aminoimidazole-4-carboxamide riboside exert synergistic anticancer action against human breast cancer and hepatocellular carcinoma

查看全文 作　　者：Xiao-liang [1,4]CHENG;Tian-yan [1,2]ZHOU;[3]BOLI;Meng-yao [2]LI;Liang [1,2]LI;Zai-quan [3]LI;Wei [1,2]LU

机构地区：[1]State Key Laboratory of Natural and Biomimetic Drugs, Peking University Health Science Center, Beijing 100191, China;[2]Department of Pharmaceutics, School of Pharmaceutical Sciences, Peking University Health Science Center, Beijing 100191, China;[3]Department of Radiation Medicine, School of Basic Medical Sciences, Peking University Health Science Center, Beijing 100191, China;[4]Department of Pharmacy, the First Affiliated Hospital of Medical College, Xian Jiaotong University, Xi-an 710061, China

出　　处：《Acta Pharmacologica Sinica》索引2013年第34卷第7期,共9页

关键词：核糖核苷酸人肝癌细胞株抗癌作用甲氨蝶呤乳腺癌甲酰胺协同 HepG2细胞

相关文献

参考文献（36）
引证文献（3）
耦合文献（12）

参考文献(36)

引证文献(3)

耦合文献(12)

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

Methotrexate and 5-aminoimidazole-4-carboxamide riboside exert synergistic anticancer action against human breast cancer and hepatocellular carcinoma

参考文献(36)

引证文献(3)

耦合文献(12)

用户提示